Self-dilation as a treatment for resistant, benign esophageal strictures

Ivana Dzeletovic, David E. Fleischer, Michael D. Crowell, Rahul Pannala, Lucinda A. Harris, Francisco C Ramirez, George E. Burdick, Lauri A. Rentz, Robert V. Spratley, Susan D. Helling, Jeffrey A. Alexander

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Goals and Background: Simple benign strictures may be relieved with one to three dilation sessions. Resistant benign strictures are anatomically complex and resistant to therapy. We sought to determine the efficacy and safety of esophageal self-dilation with bougie dilators in the largest series to date. Study: A retrospective chart review was performed to identify patients who underwent esophageal self-dilation at two tertiary referral centers (Mayo Clinic, Scottsdale, Arizona and Mayo Clinic Rochester, Minnesota) between January 1, 2003 and June 30, 2012. Demographic details and clinical information regarding relief of dysphagia, complications, and frequency of endoscopic and self-dilation were abstracted. Results: Of the 32 patients who began self-dilation for nonmalignant strictures, 30 [22 men; median (range) age, 62 years (22-86 years)] were included in the study. Median (range) follow-up was 37 months (14-281 months). Stricture etiology included radiation therapy (n = 8), anastomotic stricture (n = 9), eosinophilic esophagitis (n = 4), caustic ingestion (n = 3), photodynamic therapy (n = 2), granulation tissue (n = 2), peptic stricture (n = 1) and one patient had radiation therapy and peptic stricture. The average number (range) of physician performed dilations before self-dilation was 12 (4-55). Esophageal self-dilation was successful in treating 90 % of patients. Dysphagia score (2 vs. 1; P < 0.001), stricture diameter (median; 5 vs. 12 mm; P < 0.001) and weight (median; 73 vs. 77 kg; P < 0.001) were significantly different between EDG dilation versus self-dilation. Conclusions: Esophageal self-dilation is a safe, effective treatment for resistant, benign esophageal strictures. This management strategy should be strongly considered in this patient population.

Original languageEnglish (US)
Pages (from-to)3218-3223
Number of pages6
JournalDigestive Diseases and Sciences
Volume58
Issue number11
DOIs
StatePublished - Nov 2013

Fingerprint

Esophageal Stenosis
Dilatation
Pathologic Constriction
Therapeutics
Deglutition Disorders
Digestion
Radiotherapy
Eosinophilic Esophagitis
Caustics
Granulation Tissue
Photochemotherapy
Tertiary Care Centers
Retrospective Studies
Eating
Demography

Keywords

  • Dysphagia
  • Endoscopic dilation
  • Esophageal self-dilation
  • Resistant benign esophageal strictures

ASJC Scopus subject areas

  • Gastroenterology
  • Physiology

Cite this

Dzeletovic, I., Fleischer, D. E., Crowell, M. D., Pannala, R., Harris, L. A., Ramirez, F. C., ... Alexander, J. A. (2013). Self-dilation as a treatment for resistant, benign esophageal strictures. Digestive Diseases and Sciences, 58(11), 3218-3223. https://doi.org/10.1007/s10620-013-2822-7

Self-dilation as a treatment for resistant, benign esophageal strictures. / Dzeletovic, Ivana; Fleischer, David E.; Crowell, Michael D.; Pannala, Rahul; Harris, Lucinda A.; Ramirez, Francisco C; Burdick, George E.; Rentz, Lauri A.; Spratley, Robert V.; Helling, Susan D.; Alexander, Jeffrey A.

In: Digestive Diseases and Sciences, Vol. 58, No. 11, 11.2013, p. 3218-3223.

Research output: Contribution to journalArticle

Dzeletovic, I, Fleischer, DE, Crowell, MD, Pannala, R, Harris, LA, Ramirez, FC, Burdick, GE, Rentz, LA, Spratley, RV, Helling, SD & Alexander, JA 2013, 'Self-dilation as a treatment for resistant, benign esophageal strictures', Digestive Diseases and Sciences, vol. 58, no. 11, pp. 3218-3223. https://doi.org/10.1007/s10620-013-2822-7
Dzeletovic, Ivana ; Fleischer, David E. ; Crowell, Michael D. ; Pannala, Rahul ; Harris, Lucinda A. ; Ramirez, Francisco C ; Burdick, George E. ; Rentz, Lauri A. ; Spratley, Robert V. ; Helling, Susan D. ; Alexander, Jeffrey A. / Self-dilation as a treatment for resistant, benign esophageal strictures. In: Digestive Diseases and Sciences. 2013 ; Vol. 58, No. 11. pp. 3218-3223.
@article{7ad46f43fd754f54962e8daf9a86188d,
title = "Self-dilation as a treatment for resistant, benign esophageal strictures",
abstract = "Goals and Background: Simple benign strictures may be relieved with one to three dilation sessions. Resistant benign strictures are anatomically complex and resistant to therapy. We sought to determine the efficacy and safety of esophageal self-dilation with bougie dilators in the largest series to date. Study: A retrospective chart review was performed to identify patients who underwent esophageal self-dilation at two tertiary referral centers (Mayo Clinic, Scottsdale, Arizona and Mayo Clinic Rochester, Minnesota) between January 1, 2003 and June 30, 2012. Demographic details and clinical information regarding relief of dysphagia, complications, and frequency of endoscopic and self-dilation were abstracted. Results: Of the 32 patients who began self-dilation for nonmalignant strictures, 30 [22 men; median (range) age, 62 years (22-86 years)] were included in the study. Median (range) follow-up was 37 months (14-281 months). Stricture etiology included radiation therapy (n = 8), anastomotic stricture (n = 9), eosinophilic esophagitis (n = 4), caustic ingestion (n = 3), photodynamic therapy (n = 2), granulation tissue (n = 2), peptic stricture (n = 1) and one patient had radiation therapy and peptic stricture. The average number (range) of physician performed dilations before self-dilation was 12 (4-55). Esophageal self-dilation was successful in treating 90 {\%} of patients. Dysphagia score (2 vs. 1; P < 0.001), stricture diameter (median; 5 vs. 12 mm; P < 0.001) and weight (median; 73 vs. 77 kg; P < 0.001) were significantly different between EDG dilation versus self-dilation. Conclusions: Esophageal self-dilation is a safe, effective treatment for resistant, benign esophageal strictures. This management strategy should be strongly considered in this patient population.",
keywords = "Dysphagia, Endoscopic dilation, Esophageal self-dilation, Resistant benign esophageal strictures",
author = "Ivana Dzeletovic and Fleischer, {David E.} and Crowell, {Michael D.} and Rahul Pannala and Harris, {Lucinda A.} and Ramirez, {Francisco C} and Burdick, {George E.} and Rentz, {Lauri A.} and Spratley, {Robert V.} and Helling, {Susan D.} and Alexander, {Jeffrey A.}",
year = "2013",
month = "11",
doi = "10.1007/s10620-013-2822-7",
language = "English (US)",
volume = "58",
pages = "3218--3223",
journal = "Digestive Diseases and Sciences",
issn = "0163-2116",
publisher = "Springer New York",
number = "11",

}

TY - JOUR

T1 - Self-dilation as a treatment for resistant, benign esophageal strictures

AU - Dzeletovic, Ivana

AU - Fleischer, David E.

AU - Crowell, Michael D.

AU - Pannala, Rahul

AU - Harris, Lucinda A.

AU - Ramirez, Francisco C

AU - Burdick, George E.

AU - Rentz, Lauri A.

AU - Spratley, Robert V.

AU - Helling, Susan D.

AU - Alexander, Jeffrey A.

PY - 2013/11

Y1 - 2013/11

N2 - Goals and Background: Simple benign strictures may be relieved with one to three dilation sessions. Resistant benign strictures are anatomically complex and resistant to therapy. We sought to determine the efficacy and safety of esophageal self-dilation with bougie dilators in the largest series to date. Study: A retrospective chart review was performed to identify patients who underwent esophageal self-dilation at two tertiary referral centers (Mayo Clinic, Scottsdale, Arizona and Mayo Clinic Rochester, Minnesota) between January 1, 2003 and June 30, 2012. Demographic details and clinical information regarding relief of dysphagia, complications, and frequency of endoscopic and self-dilation were abstracted. Results: Of the 32 patients who began self-dilation for nonmalignant strictures, 30 [22 men; median (range) age, 62 years (22-86 years)] were included in the study. Median (range) follow-up was 37 months (14-281 months). Stricture etiology included radiation therapy (n = 8), anastomotic stricture (n = 9), eosinophilic esophagitis (n = 4), caustic ingestion (n = 3), photodynamic therapy (n = 2), granulation tissue (n = 2), peptic stricture (n = 1) and one patient had radiation therapy and peptic stricture. The average number (range) of physician performed dilations before self-dilation was 12 (4-55). Esophageal self-dilation was successful in treating 90 % of patients. Dysphagia score (2 vs. 1; P < 0.001), stricture diameter (median; 5 vs. 12 mm; P < 0.001) and weight (median; 73 vs. 77 kg; P < 0.001) were significantly different between EDG dilation versus self-dilation. Conclusions: Esophageal self-dilation is a safe, effective treatment for resistant, benign esophageal strictures. This management strategy should be strongly considered in this patient population.

AB - Goals and Background: Simple benign strictures may be relieved with one to three dilation sessions. Resistant benign strictures are anatomically complex and resistant to therapy. We sought to determine the efficacy and safety of esophageal self-dilation with bougie dilators in the largest series to date. Study: A retrospective chart review was performed to identify patients who underwent esophageal self-dilation at two tertiary referral centers (Mayo Clinic, Scottsdale, Arizona and Mayo Clinic Rochester, Minnesota) between January 1, 2003 and June 30, 2012. Demographic details and clinical information regarding relief of dysphagia, complications, and frequency of endoscopic and self-dilation were abstracted. Results: Of the 32 patients who began self-dilation for nonmalignant strictures, 30 [22 men; median (range) age, 62 years (22-86 years)] were included in the study. Median (range) follow-up was 37 months (14-281 months). Stricture etiology included radiation therapy (n = 8), anastomotic stricture (n = 9), eosinophilic esophagitis (n = 4), caustic ingestion (n = 3), photodynamic therapy (n = 2), granulation tissue (n = 2), peptic stricture (n = 1) and one patient had radiation therapy and peptic stricture. The average number (range) of physician performed dilations before self-dilation was 12 (4-55). Esophageal self-dilation was successful in treating 90 % of patients. Dysphagia score (2 vs. 1; P < 0.001), stricture diameter (median; 5 vs. 12 mm; P < 0.001) and weight (median; 73 vs. 77 kg; P < 0.001) were significantly different between EDG dilation versus self-dilation. Conclusions: Esophageal self-dilation is a safe, effective treatment for resistant, benign esophageal strictures. This management strategy should be strongly considered in this patient population.

KW - Dysphagia

KW - Endoscopic dilation

KW - Esophageal self-dilation

KW - Resistant benign esophageal strictures

UR - http://www.scopus.com/inward/record.url?scp=84889570388&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84889570388&partnerID=8YFLogxK

U2 - 10.1007/s10620-013-2822-7

DO - 10.1007/s10620-013-2822-7

M3 - Article

C2 - 23925823

AN - SCOPUS:84889570388

VL - 58

SP - 3218

EP - 3223

JO - Digestive Diseases and Sciences

JF - Digestive Diseases and Sciences

SN - 0163-2116

IS - 11

ER -